# Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer

> **NCT00735878** · PHASE1,PHASE2 · TERMINATED · sponsor: **Konstantin Dragnev** · enrollment: 20 (actual)

## Conditions studied

- Non Small Cell Lung Cancer
- Lung Cancer

## Interventions

- **DRUG:** ABT-751 and Carboplatin

## Key facts

- **NCT ID:** NCT00735878
- **Lead sponsor:** Konstantin Dragnev
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-09
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** data from a similar did not show efficacy.
- **Last updated:** 2018-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00735878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00735878, "Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00735878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*